C. Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 301: F997-F1004, 2011. First published August 10, 2011 doi:10.1152/ajprenal.00264.2011.-Renal organic cation transporters are downregulated by nitric oxide (NO) in rat endotoxemia. NO generated by inducible NO synthase (iNOS) is substantially increased in the renal cortex after renal ischemiareperfusion (I/R) injury. Therefore, we investigated the effects of iNOS-specific NO inhibition on the expression of the organic cation transporters rOct1 and rOct2 (Slc22a1 and Slc22a2, respectively) after I/R injury both in vivo and in vitro. In vivo,
THE EPITHELIAL CELLS OF THE proximal tubuli in the kidneys effectively eliminate numerous organic anions and cations, including endogenous substances, metabolic wastes, and xenobiotics and their metabolites via renal excretion. This is accomplished by transport processes mediated by plasma membrane transporters. With respect to organic cations, such transepithelial transport is mainly mediated via the basolateral uptake transporters Oct1 (Slc22a1), Oct2 (Slc22a2), and to a minor extent Oct3 (Slc22a3), whereas the apical efflux step is mediated largely by the ATP-binding cassette (ABC) transporter P-glycoprotein (pGP; Abcb1) (13) .
After renal ischemia-reperfusion (I/R) injury, nitric oxide (NO) is produced in renal tissue in deleterious amounts. This increase in NO production is due to a substantial increase in the NO-producing enzyme inducible NO synthase (iNOS), which is well known to take place after renal ischemia and subsequent reperfusion (4) . We recently reported that this happens if I/R injury is simulated in vitro in rat proximal tubular cells (NRK-52E) in culture (23) .
In an in vivo rat model of LPS-induced endotoxemia, Heemskerk et al. (6) show that the amounts of rOct1 and rOct2 are diminished due to NO generated by iNOS. As there is some evidence that the renal excretory transport of organic cationic substances is reduced after renal I/R injury (17), we therefore hypothesized that this may be also due to a similar mechanism also involving NO generated after ischemia.
Concordant with the detoxifying role of pGP in rat kidneys, its upregulation is described after renal I/R injury (8) , and during endotoxemia (5) . This pGP upregulation is most likely under the direct influence of NO produced by iNOS, at least in the case of endotoxemia (6) . This means that the diminishment of organic cation clearance after the I/R injury cannot be due to pGP. Moreover, the rate-limiting step of organic cation excretion is determined by proximal tubular influx carriers, in particular the Octs, rather than by apically located transporters (e.g., Octn2, MATE1, and MATE2) or pGP as mentioned above (6) , (16) . The influx of a huge variety of organic cations is mediated by the OCTs. Until now, three isoforms have been identified: Oct1 (Slc22a1), Oct2 (Slc22a2), and Oct3 (Slc22a3). In rat kidneys, rOct1 and rOct2 equally contribute to organic cation uptake, whereas Oct2 is the principal isoform in humans (12) . Oct3 expression is reported to be relatively low in the kidneys (28) , leading to the assumption that its role in organic anion excretion is negligible (6) . Furthermore, basolaterally expressed Octn1 is also known to be of minor importance in organic cation flux (31) .
Therefore, in the present study, we investigated whether renal I/R injury downregulates the rate-limiting organic cation transporters rOct1 and rOct2 (and rOct3), and thus the role of NO. To determine this, renal cortical expression of rat Octs and organic cation transport were investigated in a well-established in vivo model of ischemic acute kidney injury (iAKI) after 24 h (26). We investigated the same phenomenon in a recently established proximal tubular in vitro model system of I/R injury in parallel (23) .
MATERIALS AND METHODS

In Vivo Experimental Procedure
I/R injury was induced in rats by bilateral clamping of the renal arteries for 45 min followed by a reperfusion period of 24 h as described previously (26) . Female Sprague-Dawley (SD) rats (200 -250 g body wt) were obtained from Charles River Wiga (Kissleg, Germany). Anesthesia was performed by intraperitoneal application of xylazine hydrochloride (10 mg/kg body wt) and ketamine (100 mg/kg body wt). All operative procedures were performed on thermoregulated heating boards to maintain body temperature at 37°C. Postoperative pain relief was ensured by subcutaneously applied tramadol (0.05 mg/kg body wt); postoperative dehydration was prevented by subcutaneous administration of an additional 1.0 ml of 0.9% NaCl. Animals were divided into the subgroups described below.
Clamping group (bilateral clamping and supplementation with saline). Both kidneys were carefully prepared by a bilateral flank incision. Renal arteries were dissected and temporarily ligated on both sides to simultaneously start clamping with microclips.
Sham group (sham operation and supplementation with saline). The same procedure as that for the clamping group was performed, except that the renal arteries were not clamped.
Clamping group (respectively sham group) receiving L-NIL. iNOS was specifically inhibited by 3 mg/kg L-NIL given intraperitoneally 10 min before the end of clamping (or after the sham operation) period to ensure immediate delivery into the kidneys right at the beginning of reperfusion and exclude preconditioning pretreatment effects before ischemia.
Control group (untreated animals). Animals with no previous treatment were investigated. These animals reflect day 0.
Renal function was determined by measurement of inulin clearance reflecting glomerular filtration rate in vivo after the respective experimental procedures by detection of the FITC-inulin (Sigma-Aldrich, St. Louis, MO) concentration in plasma and urine samples that were taken 24 h after the I/R injury, as described previously in detail (26) . Inulin clearance was calculated as follows: inulin clearance ϭ (inulin U ϫ VU)/(inulinP ϫ t), where inulinU is inulin concentration in urine; VU is urine volume; inulinP is inulin concentration in plasma; and t is time of measurement.
All animal care and experimental procedures performed in this study were in accordance with the German laws for animal protection.
Serotonin clearance. Serotonin was determined with a competitive ELISA technique using a Serotonin ELISA Kit (Labor Diagnostika Nord, Nordhorn, Germany). Measurements and calculations were performed in a 96-well plate according to the manufacturer's instructions. Serotonin clearance was calculated in methodical analogy to inulin clearance as already mentioned above. The fractional excretion of serotonin was calculated as the quotient of serotonin clearance and glomerular filtration.
Detection of NO. The amounts of nitrate and nitrite in plasma obtained from the in vivo I/R experiments were determined as a measure of NO generation. Detection was performed using a nitrate/nitrite colorimetric assay kit obtained from Cayman Chemical (Ann Arbor, MI) in a 96-well plate according to the manufacturer's protocol.
In Vitro Experimental Procedure
Cell culture. NRK-52E cells were obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany). NRK-52E cells were cultured in DMEM enriched with 26 mmol/l NaHCO3 and 5% (vol/vol) fetal calf serum. Cells were maintained in culture at 37°C in a humidified 5% CO2-95% air atmosphere. NRK-52E cells were appropriately cultured in culture flasks (Falcon, BectonDickinson Labware, Franklin Lakes, NJ). The cells were maintained at pH 7.4 and 37°C and gassed with 95% air-5% CO2. All studies were performed with NRK-52E cells between passages 10 and 30. The seeding density was 0.4 ϫ 10 6 cm Ϫ2 . The medium was changed every 3 days, and the cells were used for experiments at day 5 after seeding. All experiments were performed with cells that were serum-starved for 24 h.
In vitro I/R model. In vitro ischemia was induced as described previously (23) . For experiments, cells were grown in cell culture dishes (3.5-cm diameter). Control cells were exposed to bicarbonate-HEPES-buffered Ringer solution adjusted to pH 7.4 (24.0 mM NaHCO3, 0.8 mM Na2HPO4, 0.2 mM NaH2PO4, 86.5 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl 2, 0.8 mM MgCl2, 20 mM HEPES; pH was adjusted with 1 N NaOH) containing 5 mM glucose and kept at 37°C and ambient PO 2. Model ischemia was applied by exposing the cells to a bicarbonate-MES-buffered Ringer solution at pH 6.6 (4.5 mM NaHCO 3, 0.8 mM Na2HPO4, 0.2 mM NaH2PO4, 106.0 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl 2, 0.8 mM MgCl2, 20 mM MES; pH was adjusted to 6.6 with 1 N NaOH) with 5 mM mannitol (instead of glucose) and at an O 2 fraction below 1%. Buffer volumes were 1 ml/culture dish. According to what was described in detail before (23, 24) , cells were exposed to either control or ischemic (pH 6.6, aglycemia, O 2 fraction below 1%) conditions for 2 h and then cultivated under standard cell culture conditions (2 ml/culture dish) representing a reperfusion period for 48 h. The cells were exposed to hypoxic conditions using a hermetic chamber filled with 95% N 2 and 5% CO2 (see acidosis). During filling, the O 2 fraction was measured and filling was continued until the O 2 fraction in the chamber decreased below 1%. An O 2 fraction Ͻ1% represents a PO2 Ͻ7.6 mmHg, which is well within the range of measured values in clamped kidneys (20) and well below the critical PO 2 for oxygen consumption in the kidney cortex (14) . The O 2 fraction was stable throughout the 2-h incubation period. Acidosis occurs during renal ischemia in vivo, and a pH of 6.6 is described in renal tissue (7) . The stability of pH was ensured by using a bicarbonate-MES-buffered Ringer solution in a 5% CO 2 atmosphere. Correct pH was ensured by measurement before and after the incubation period. Aglycemia mimics the absence of glucose due to consumption without redelivery in ischemia and was applied by using a glucose-free buffer as mentioned above.
In vitro uptake studies.
uptake into suspended NRK-52E cells was measured as described previously (19) . Confluent cells were detached, collected by centrifugation at 1,000 g for 10 min, and suspended at 37°C in PBS containing 0.5 mM MgCl2 and 1 mM CaCl2 (transport PBS). Cells were incubated for 10 s at 37°C in transport PBS containing 0.1 M 
Molecular Biological Methods
Protein immunoblotting. For Western blot analysis, frozen kidney cortices were mechanically homogenized, dissolved in lysis buffer containing 150 mM NaCl, 10 mmol/l Tris (Base) pH 7.3, 1% Nonidet P-40 (Igepal), 0.1% SDS, 1% sodium desoxychloric acid, 0.1% Triton X-100, 1 mM EDTA, 184 mg/l sodium orthovanadate, and 0.1% protease inhibitor cocktail [100 mM AEBSF-HCl, 80 mM aprotinin (bovine lung, crystalline), 5 mM bestatin, 1.5 mM protease inhibitor E-64, 2 mM leupeptin hemisulfate, and 1 mM pepstatin A]. Total protein was measured in each sample using the Bradford method (1).
Protein samples were analyzed by Western blotting using an 8% gel with a protein load of 20 g for rOct1 and 25 g for rOct2 and rOct3, with the respective antibodies diluted in 5% goat serum as indicated.
Anti-rat Oct1 polyclonal antibody (dilution 1:1,000) was raised against amino acids 524 -542 of rOCT1 (ETIEEAENLGRRK-SKAKEN) and affinity purified using the antigenic peptide. The antibody was prepared, purified, and characterized as described previously (11) . Anti-rat Oct2 polyclonal antibody (host: rabbit; dilution 1:1,000) and anti-rat Oct3 polyclonal (host: rabbit; dilution 1:2,000) were purchased from Alpha Diagnostic International (San Antonio, TX, USA). Blots were subsequently incubated with horseradish per-oxidase-conjugated anti-rabbit IgG (1:3,000, Dako, Hamburg, Germany) and were developed using a chemiluminescence kit (Forte, Millipore, Billerica, MA) following the manufacturer's instructions (Amersham, GE Healthcare, Buckinghamshire, UK). Blots were analyzed by densitometry using ImageJ software (www.rsbweb.nhi.gov/ ij). Any presented Western blot data of protein expression were corrected for the respective loading control (␤-actin as reference protein).
Real-time RT-PCR. RNA from kidney cortices was extracted using a Qiagen RNA Isolation Kit (Qiagen, Hilden, Germany). The RNA concentration was determined, and cDNA was synthesized using an iScript cDNA synthesis kit (Bio-Rad Laboratories, Benicia, CA) according to the manufacturer's instructions. Oligonucleotide primers and PCR protocols were as described previously (15) . In brief, RT-PCR was performed according to the iQ SYBR-Green Supermix RT-PCR system protocol (Bio-Rad Laboratories). Initial denaturation was performed for 3 min at 95°C. PCR amplification was performed for 45 cycles at 95°C for 20 s, 60°C for 20 s, and 72°C for 20 s. The final elongation step was 72°C for 10 min. For rOct1, the primers were 5=-tggccgtaagctctgtctct-3= (sense) and 5=-tcaaggtatagccggacacc-3= (antisense), resulting in a 151-bp RT-PCR product. For rOct2, the primers were 5=-atgacgcctttcctcgtcta-3= (sense) and 5=-ctgcatattctcggcatcct-3= (antisense), resulting in a 161-bp RT-PCR product. For rOct3, the primers were 5=caatgggaaacacctctcgt-3= (sense) and 5=-atacaccacggcacttgtga-3= (antisense), resulting in a 153-bp RT-PCR product. For ␤-actin, the primers were 5=-tctacaatgagctgcgtgtg-3= (sense) and 5=-tacatggctggggtgttgaa-3= (antisense), resulting in a 129-bp RT-PCR product as described previously (23) . The RT-PCR products were tested for the correct size by agarose gel electrophoresis and melting point analysis. The products were quantified using the ⌬⌬C T method with ␤-actin as a reference gene. Expression in sham animals was normalized to 1.
Materials
Tramadol (Tramal) was from Grünenthal (Aachen, Germany), xylazine hydrochloride (Rompun) was from Bayer (Leverkusen, Germany), and ketamine (Ketanest) was from Pharmacia and Upjohn (Bridgewater, NJ). If not indicated otherwise, all substances were diluted in 0.9% NaCl (wt/vol). If not stated otherwise, chemicals were from Sigma-Aldrich.
Data Analysis
Data are presented as means Ϯ SE. The n values are given in the text and figures. For all experiments, n equals the number of rats or experiments (RT-PCR, Western blotting) with tissue or tissue extractions from distinctive rats. Statistical significance was determined by unpaired Student's t-tests or ANOVA where appropriate. Data from sham-operated animals were tested against untreated controls, and data from clamped animals were tested against sham-operated ones. Differences were considered statistically significant at P Ͻ 0.05.
RESULTS
Effect of N 6 -(1-Iminoethyl)-L-Lysine on NO Levels and Renal Function After I/R Injury In Vivo
The amount of nitrate/nitrite in plasma was determined using the well-accepted measure of NO generation after iAKI caused by renal I/R injury (2) . As shown in Fig. 1 , renal ischemia followed by reperfusion clearly increased NO, whereas this was not the case after the specific inhibition of iNOS by administering 3 mg/kg N 6 -(1-iminoethyl)-L-lysine (L-NIL) at the end of the ischemic period. Thus L-NIL totally abolishes NO generation by iNOS inhibition after renal I/R injury in vivo.
Inulin clearance was determined as a measure of renal function. Inulin clearance was 0.58 Ϯ 0.077 ml/min (n ϭ 11) in untreated controls and 0.57 Ϯ 0.040 ml/min (n ϭ 9) in sham-operated animals, indicating that surgical intervention had no effect on glomerular filtration rate. These values agree well with previously published data (26) , indicating that this model is reproducible and reliable. As expected, iAKI caused by I/R injury decreased inulin clearance to 0.19 Ϯ 0.023 ml/min (n ϭ 11). In sham treated animals, after the administration of 3 mg/kg L-NIL dihydrochloride, inulin clearance increased significantly to 0.83 Ϯ 0.058 ml/min (n ϭ 5). This was also the case in animals after I/R injury receiving L-NIL. Treatment with L-NIL led to an inulin clearance of 0.44 Ϯ 0.049 ml/min, which indicates that L-NIL has a beneficial effect on renal function after I/R injury as described previously (2) .
Effect of L-NIL on Oct1, Oct2, and Oct3 Expression in Rat Renal Cortex After I/R Injury In Vivo
Since NO increased after I/R injury and L-NIL abolished this increase, it seems reasonable to investigate rOct1, rOct2, and rOct3 expression in the rat renal cortex under these circumstances. As indicated in Fig. 2 , the amounts rOct1 and rOct2, but not rOct3 were reduced after ischemia and 24-h reperfusion in vivo. The application of L-NIL (3 mg/kg after ischemia) totally abrogated the downregulation of both rOct1 and rOct2. In sham-treated animals, L-NIL had no effect on the amount of either transporter. Levels of rOct3 were not affected by either ischemia and subsequent reperfusion or L-NIL.
Next, we investigated whether the amounts of rOct1 and/or rOct2 mRNA in this cortical specimen are also reduced after I/R injury. Since there was no detectable effect on rOct3 protein levels, we did not investigate its mRNA regulation. As Shown is a bar graph of nitrate/nitrite plasma concentrations reflecting NO generation in the control group (0 h), sham group, clamping (clamp) group, and sham and clamping groups after L-NIL application (3 mg/kg body wt) in SpragueDawley rats in vivo 24 h after the respective procedure. Nitrate/nitrite was determined using a colorimetric assay as described in MATERIALS AND METH-ODS. *Statistically significant difference between sham-operated and clamped animals (P Ͻ 0.05); n is shown inside the respective bars. indicated in Fig. 3, rOct1 and rOct2 mRNA levels were reduced after ischemia and 24-h reperfusion. The application of L-NIL (3 mg/kg after ischemia) completely abrogated the downregulation of both rOct1 and rOct2 mRNA. In shamtreated animals, L-NIL had no effect on the mRNA levels of either transporter. As mentioned previously, rOct3 is thought to be of minor importance for renal organic cation excretion. This is highlighted by the fact that rOct3 mRNA was markedly lower in the rat kidney cortex than both rOct1 (⌬C t ϭ 10) and rOct2 (⌬C t ϭ 12). Fig. 2 . Effect of iNOS inhibition by L-NIL on the protein expression of rat organic cation transporters rOct1, rOct2, and rOct3 in renal cortex after I/R injury in vivo. Shown are rOct1 protein expression (A), rOct2 protein expression (B), and rOct3 protein expression (C) in the sham group, clamping (clamp) group, and both sham and clamping groups after L-NIL application (3 mg/kg body wt) in Sprague-Dawley rats in vivo 24 h after the respective procedure. The respective expression of ␤-actin served as reference of precise protein load. *Statistically significant difference between sham-operated and clamped animals (P Ͻ 0.05); n is given inside the respective bars. Representative Western blot (D) of rOct1, rOct2, and rOct3 protein expression (top) and respective ␤-actin loading control (bottom) in renal cortical homogenates is depicted with the respective protein weight. Total protein, generated from kidney cortex, was homogenized and processed for Western blotting as described in MATERIALS AND METHODS.
Effect of L-NIL on Fractional Excretion of Serotonin in Rats After I/R Injury In Vivo
To functionally investigate the effects of L-NIL on proximal tubular organic cation excretory transport, we investigated the renal fractional excretion of the endogenous cationic metabolite serotonin. Serotonin is a known substrate of Oct1 in rodents and is probably also transported by Oct2 (13) . As shown in Fig. 4 , I/R injury substantially diminished the fractional excretion of serotonin. The application of L-NIL improved the fractional excretion of serotonin to the levels of the control and sham animals. In sham animals, L-NIL had no effect on the fractional excretion of serotonin.
Effect of L-NIL on Oct1, Oct2, and Oct3 Expression After I/R Injury In Vitro
A large extent of iNOS expression takes place in proximal tubular cells after ischemia (3) . Moreover, we previously showed that iNOS expression is elevated during reperfusion after model ischemia in our in vitro proximal tubular cell model (23) . Therefore, we investigated whether proximal tubular cells are able to mediate the downregulation of rOcts in an autocrine fashion, at least in principle. The expression of rOcts was investigated by real-time RT-PCR after a 2-h model ischemia and 48-h reperfusion as alterations of key parameters following I/R damage in this specific conditions of our model I/R injury reflect those of the in vivo system (23, 24) . The expression of both rOct1 and rOct2 diminished substantially after model I/R injury applied to isolated proximal tubular cells (Fig. 5) . Parallel to the in vivo situation, the application of L-NIL (30 M) abolished this effect. This indicates that the I/R injury-induced downregulation of rOct1 and rOct2 by NO may in fact be an autocrine mechanism of the proximal tubule.
Effect of L-NIL on Organic Cation Transport After I/R Injury In Vitro
Next, we tested whether the regulation mentioned above is also present at the functional level and is therefore most likely present at the protein level as well. For this purpose, we investigated the basolateral uptake of the prototypical organic cation MPP into proximal tubular NRK-52E cells after control treatment or model I/R injury. As presented in Fig. 6 , ischemia and 48-h reperfusion led to a substantial reduction of organic cation uptake in vitro. Moreover, L-NIL application after I/R injury completely restored MPP uptake up to control values. Fig. 4 . Effect of iNOS inhibition by L-NIL on the renal handling of the endogenous organic cation serotonin in Sprague-Dawley rats after I/R injury in vivo. Shown is bar graph of the fractional excretion the endogenous Oct substrate serotonin in the control group (0 h), sham group, clamping (clamp) group, and both sham and clamping groups after L-NIL application (3 mg/kg body wt) in Sprague-Dawley rats in vivo 24 h after the respective procedure. Fractional excretion of serotonin was calculated as the quotient of serotonin clearance and glomerular filtration. *Statistically significant difference between sham-operated and clamped animals (P Ͻ 0.05); n is given inside the respective bars. Fig. 3 . Effect of iNOS inhibition by L-NIL on the mRNA levels of rOct1 and rOct2 in renal cortex after I/R injury in vivo. Shown is a bar graph of rOct1 mRNA expression (A) and rOct2 mRNA expression (B) in the control group (0 h), sham group, clamping (clamp) group, and both sham and clamping groups after L-NIL application (3 mg/kg body wt) in Sprague-Dawley rats in vivo 24 h after the respective procedure. Total RNA was isolated from kidney cortex. Real-time PCR against rOct1, rOct2, and ␤-actin was performed as described in MATERIALS AND METHODS. Quantification was performed using the ⌬⌬CT method using ␤-actin as the reference gene, and expression in sham-treated control animals (sham) was normalized to 1. The amount of respective mRNA signal is normalized to the respective signal from ␤-actin. *Statistically significant difference between sham-operated and clamped animals (P Ͻ 0.05); n is given inside the respective bars. L-NIL alone had no effect on organic cation uptake in control cells. Therefore, the in vitro data 1) accurately reflect the in vivo situation and 2) indicate that the observed effect may be of an autocrine fashion in principle.
DISCUSSION
The effect of ischemia on renal function observed after 24-h reperfusion is corroborated by previously published data (27) , (26) , indicating that this in vivo model system of ischemic acute kidney injury is reliable and reproducible. Investigations of the time response of organic cation transporter expression (data not shown) and renal function after renal ischemia (27) reveal a maximum detrimental effect 24 h after renal I/R injury. A single dose of L-NIL (3 mg/kg body wt) was administered intraperitoneally at the end of ischemia. The upregulation of iNOS is a hallmark of renal I/R injury (4); excess NO generated by iNOS is thought to play a pivotal role in this process. Thus the beneficial effect of L-NIL on renal function after ischemia and subsequent reperfusion is most likely due to the impairment of deleterious amounts of iNOS-induced NO.
As indicated by qPCR and Western blotting, L-NIL prevents the I/R-induced downregulation of both rOct1 (Slc22a1) and rOct2 (Slc22a2) in vivo. This agrees well with the working hypothesis developed in detail in the introduction, indicating that I/R-induced NO leads to the downregulation of rOct1 (Slc22a1) and rOct2 (Slc22a2). Thus L-NIL should also improve the secretion of the endogenous organic cation transporter substrate serotonin, since it is a known substrate of Oct1 and is probably also transported by Oct2 in rodents; this is indeed clearly indicated by measurements of the fractional excretion of serotonin. Thus the regulation of rOct1 (Slc22a1) and rOct2 (Slc22a2) expression is functionally relevant with respect to the renal excretion of organic cations of endogenous origin. In vitro, L-NIL also prevents impaired rOct1 (Slc22a1) and rOct2 (Slc22a2) expression as indicated by qPCR; the latter is functionally reflected by an impaired uptake of the organic cation MPP, a well-known substrate for Oct1, Oct2, and Oct3 of various species, which is also prevented by L-NIL. This indicates that the same regulatory pattern holds true at the protein level in vitro; this is further indicated by in vivo data showing identical regulatory patterns at the mRNA and protein levels. Therefore, the in vitro data 1) accurately reflect the in vivo situation and 2) indicate that the observed effect may be of an autocrine fashion in principle.
The detailed mechanism by which NO reduces rOct1 (Slc22a1) and rOct2(Slc22a2) expression after I/R injury remains unclear. It is known from in vitro studies that rOct1-mediated transport is enhanced by PKC, PKA, and endogenous tyrosine kinases (18) and is inhibited by cGMP (25) . The Shown is a bar graph of rOct1 mRNA expression (A) and rOct2 mRNA expression (B) in the control group, I/R group, and both groups after L-NIL application (30 M L-NIL) in NRK-52E renal tubular epithelial cells in vitro 48 h after the respective procedure. Total RNA was generated from NRK-52E cells. Realtime PCR against rOct1, rOct2, and ␤-actin was performed as described in MATERIALS AND METHODS. Quantification was performed using the ⌬⌬CT method using ␤-actin as the reference gene, and expression in control cells was normalized to 1. The amount of respective mRNA signal is normalized to the respective signal from ␤-actin. *Statistically significant difference between control cells and cells subjected to model I/R injury (P Ͻ 0.05); n is given inside the respective bars.
activation of iNOS and subsequent NO release are known to induce cGMP production, which then inhibits rOct1-mediated transport. However, this assumption only holds true if cGMP regulates Oct1 in the long term as well, which is the case for MRP2 (22) . This must to be investigated in detail in future studies, as this is highly speculative.
Oct1/2 double-knockout mice revealed that in rodents, Oct1 (Slc22a1) and Oct2 (Slc22a2) together are essential for the renal secretion of many small organic cations (10) . Changes in the expression of renal drug transporters alter the pharmacokinetics of many drugs (29) and have implications in the prediction of overall drug deposition and excretion (21) . Thus reduced tubular uptake of organic cationic drugs may cause increased drug toxicity due to its accumulation. On the other hand, reduced drug uptake via Octs may decrease the local therapeutic efficacy within the kidneys themselves or diminish metabolic drug activation as well as metabolization in the kidneys or urinary tract. However, in conjunction with the fact that pGP is upregulated in rat kidneys after renal I/R injury (8) (as well as during endotoxemia) (5), this may represent a protective mechanism against the accumulation of potentially toxic metabolites. Reduced tubular uptake together with increased functional expression of efflux pumps could potentially lead to a decreased amount of respective compounds in the proximal tubular epithelium itself. The upregulation of pGP is most likely under the direct influence of NO produced by iNOS, at least in the case of endotoxemia (6) . As a cause, this means that the diminishment of organic cation clearance after I/R-injury cannot be due to pGP. Moreover, it has been shown that the rate-limiting step of organic cation excretion is determined by proximal tubular influx carriers rather than pGP (6, 16) or other apically located transporters (e.g., OCTN2, MATE1, and MATE2). In conjunction with our findings, this suggests that the renal clearance of serotonin is predominantly determined by the activities of rOct1 (Slc22a1) and rOct2 (Slc22a2) and not by the apical efflux step. To our knowledge, this is the first study that indicates rate-limiting roles of rOct1 (Slc22a1) or rOct1 (Slc22a1) plus rOct2(Slc22a2) for renal serotonin clearance and fractional excretion.
Recently, Heemskerk et al. (6) found similar regulatory effects on the expression of rOct1 (Slc22a1) and rOct2 (Slc22a2), and organic cation secretion after model endotoxemia induced by LPS using 100 mg/kg aminoguanidine (an iNOS inhibitor). However, in contrast to renal I/R-injury (i.e., the present study), the inhibition of NOS activity in endotoxemia did not increase rOct1 (Slc22a1) and rOct2 (Slc22a2) mRNA, indicating that NO regulates renal cation transporters at the posttranscriptional level after endotoxemia. Thus, although NO is involved in rOct1 (Slc22a1) and rOct2 (Slc22a2) regulation after both endotoxemia and renal ischemia, the mechanisms leading to their downregulation appear to be different under both circumstances.
Serotonin is known to exert harmful effects such as the induction of platelet shape change, platelet aggregation, vascular smooth muscle cell proliferation, and vasoconstriction (exhibited in atheromatous coronary vessels); it is also known to be elevated in peripheral vascular diseases (9) . As Octs are described to be downregulated in diabetes (30) , it is intriguing to speculate about the coherence of diabetes-induced renal organic cation transporter downregulation leading to increased circulating serotonin, which might subsequently be involved in the development of diabetes-associated vascular disease.
In summary, we showed that renal I/R injury downregulates rOct1 (Slc22a1) and rOct2 (Slc22a2), which are most probably mediated by NO. In principle, this may be an autocrine effect of proximal tubular epithelial cells. Furthermore, we showed that rOct1 (Slc22a1), or rOct1 (Slc22a1) and rOct2 (Slc22a2) limit the rate of the renal excretion of serotonin.
